Terazosin en es it fr

Terazosin Brand names, Terazosin Analogs

Terazosin Brand Names Mixture

  • No information avaliable

Terazosin Chemical_Formula


Terazosin RX_link


Terazosin fda sheet

Terazosin FDA

Terazosin msds (material safety sheet)

Terazosin Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Terazosin Molecular Weight

387.433 g/mol

Terazosin Melting Point

273 oC

Terazosin H2O Solubility


Terazosin State


Terazosin LogP


Terazosin Dosage Forms


Terazosin Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Terazosin Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Terazosin Absorption

Essentially completely absorbed in man (90% bioavailability).

Terazosin side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Terazosin Patient Information

Terazosin Organisms Affected

Humans and other mammals